Product Information
FLUTICASONE-SALMETEROL 232-14 is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $103.3827 per EA under NDC 00093360982. Its NADAC has been published 449 times since Nov 22, 2017.
Strength
232; 14 ug/1; ug/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093360982
Classification
Generic
Dosage Form
POWDER, METERED
Route
RESPIRATORY (INHALATION)
Last Updated
6/17/2026
Active Ingredients
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA208799On Market Since
4/28/2017
Pharmacological Classes
Price Statistics
The NADAC for FLUTICASONE-SALMETEROL 232-14 has been published 449 times since Nov 22, 2017, and over the history we have for it it has risen 21.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $103.3827 per EA |
|---|---|
| All-time high | $111.2732 (Apr 10, 2024) |
| All-time low | $82.2483 (Dec 22, 2021) |
| 52-week high | $111.0279 |
| 52-week low | $100.0103 |
| Median price | $91.2931 |
| Average price | $95.5026 |
| Largest weekly change | +17.8% (Apr 20, 2022) |
| Weeks tracked | 449 |
| Tracking since | Nov 22, 2017 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FLUTICASONE-SALMETEROL 232-14?
The current National Average Drug Acquisition Cost (NADAC) for FLUTICASONE-SALMETEROL 232-14, manufactured by Teva Pharmaceuticals USA Inc., is $103.3827 per EA (NDC 00093360982), effective Jun 24, 2026.
How has the price of FLUTICASONE-SALMETEROL 232-14 changed over time?
Over the history we have for it, the NADAC for FLUTICASONE-SALMETEROL 232-14 has risen 21.9%. It has been tracked across 449 weekly CMS publications since Nov 22, 2017.
What are the highest and lowest recorded NADAC prices for FLUTICASONE-SALMETEROL 232-14?
Since Nov 22, 2017, the NADAC for FLUTICASONE-SALMETEROL 232-14 has ranged from a low of $82.2483 (Dec 22, 2021) to a high of $111.2732 (Apr 10, 2024), with a median of $91.2931 per EA.
Are there cheaper alternatives to FLUTICASONE-SALMETEROL 232-14?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as FLUTICASONE-SALMETEROL 232-14, but none are currently priced below it.
Who manufactures FLUTICASONE-SALMETEROL 232-14?
FLUTICASONE-SALMETEROL 232-14 (NDC 00093360982) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification